Rhabdoid Tumor - 22 Studies Found
Active, not recruiting |
: Study of Safety and Efficacy in Patients With Malignant Rhabdoid Tumors (MRT) and Neuroblastoma : Malignant Rhabdoid Tumors (MRT), Neuroblastoma : 2012-12-06 : Drug: LEE011 LEE011 is a small molecule inhibitor of CDK4/6. |
Active, not recruiting |
: Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System : Childhood Atypical Teratoid/Rhabdoid Tumor : 2008-04-03 :
|
Recruiting |
: Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors :
|
Terminated |
: Antineoplaston Therapy in Treating Children With Rhabdoid Tumor of the Central Nervous System : Rhabdoid Neoplasm of CNS : 1999-11-01 : Drug: Antineoplaston therapy (Atengenal + Astugenal) Children with a Rhabdoid tumor will receive Antineo |
Completed |
: Studying Biomarkers in Samples From Young Patients With Rhabdoid Tumors : Kidney Cancer : 2012-02-29 :
|
Completed |
: Studying Gene Expression in Samples From Patients With Rhabdoid Tumors :
: 2012-03-10 :
|
Withdrawn |
: Biomarker Study in Samples From Patients With Malignant Rhabdoid Tumor of the Kidney or Atypical Teratoid Rhabdoid Tumor :
: 2011-10-01 :
|
Recruiting |
: Modified Measles Virus (MV-NIS) for Children and Young Adults With Recurrent Medulloblastoma or Recurrent ATRT :
|
Active, not recruiting |
: Treatment of Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor : Brain and Central Nervous System Tumors : 2004-06-10 :
|
Completed |
: Oxaliplatin in Treating Children With Recurrent or Refractory Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor : Brain and Central Nervous System Tumors : 2002-10-03 : Drug: Oxaliplatin |